Legal & General Group
ZLAB icon

Legal & General Group’s Zai Lab ZLAB Stock Holding History

Legal & General Group’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
71,461
+1,447
+2% +$28.6K ﹤0.01% 2094
2026
Q1 		$1.32M Sell
70,014
-317,786
-82% -$5.89M ﹤0.01% 2053
2025
Q4 		$6.84M Buy
387,800
+5,341
+1% +$125K ﹤0.01% 1403
2025
Q3 		$13M Buy
382,459
+300,623
+367% +$10.3M ﹤0.01% 1056
2025
Q2 		$2.86M Sell
81,836
-534
-0.6% -$17.6K ﹤0.01% 1820
2025
Q1 		$2.98M Sell
82,370
-357
-0.4% -$11K ﹤0.01% 1769
2024
Q4 		$2.16M Sell
82,727
-19,623
-19% -$545K ﹤0.01% 1945
2024
Q3 		$2.47M Sell
102,350
-53,934
-35% -$1.02M ﹤0.01% 1884
2024
Q2 		$2.71M Sell
156,284
-478,794
-75% -$8.42M ﹤0.01% 1805
2024
Q1 		$10.1M Sell
635,078
-41,143
-6% -$867K ﹤0.01% 1140
2023
Q4 		$18.5M Sell
676,221
-18,404
-3% -$486K 0.01% 865
2023
Q3 		$16.9M Sell
694,625
-239,977
-26% -$6.39M 0.01% 871
2023
Q2 		$25.9M Buy
934,602
+161,982
+21% +$5.3M 0.01% 771
2023
Q1 		$25.7M Buy
772,620
+45,275
+6% +$1.74M 0.01% 755
2022
Q4 		$22.3M Buy
727,345
+13,958
+2% +$440K 0.01% 788
2022
Q3 		$24.4M Buy
713,387
+90,328
+14% +$3.86M 0.01% 754
2022
Q2 		$21.6M Buy
623,059
+55,140
+10% +$1.94M 0.01% 807
2022
Q1 		$25M Buy
567,919
+1,884
+0.3% +$91.1K 0.01% 823
2021
Q4 		$35.6M Buy
566,035
+115,609
+26% +$9.8M 0.01% 753
2021
Q3 		$47.5M Buy
450,426
+2,713
+0.6% +$389K 0.02% 683
2021
Q2 		$79.2M Buy
447,713
+1,331
+0.3% +$214K 0.03% 597
2021
Q1 		$59.6M Sell
446,382
-7,222
-2% -$1.12M 0.02% 628
2020
Q4 		$61.4M Buy
453,604
+18,230
+4% +$1.86M 0.02% 600
2020
Q3 		$36.2M Buy
435,374
+224,642
+107% +$18M 0.02% 675
2020
Q2 		$17.3M Buy
210,732
+56,603
+37% +$3.83M 0.01% 823
2020
Q1 		$7.93M Buy
154,129
+145,765
+1,743% +$7.6M ﹤0.01% 977
2019
Q4 		$348K Buy
8,364
+6,232
+292% +$230K ﹤0.01% 2293
2019
Q3 		$69K Hold
2,132
– – ﹤0.01% 2634
2019
Q2 		$74K Hold
2,132
– – ﹤0.01% 2638
2019
Q1 		$63K Hold
2,132
– – ﹤0.01% 2637
2018
Q4 		$50K Hold
2,132
– – ﹤0.01% 2695
2018
Q3 		$42K Buy
+2,132
New +$46.2K ﹤0.01% 2866

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Legal & General Group's ZLAB Position: Q2 2026 in Review

Legal & General Group increased its Zai Lab (ZLAB) stake by 2.1% in Q2 2026, buying an estimated $28.6K and bringing the position to 71,461 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

Legal & General Group first reported a position in ZLAB in Q3 2018 and has held it in 32 quarters since. The position peaked at $79.2M in Q2 2021. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Legal & General Group held 71,461 shares of Zai Lab worth $1.36M as of Q2 2026.
  • Legal & General Group bought 1,447 Zai Lab shares in Q2 2026, an estimated $28.6K.
  • Zai Lab made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2094 holding.
  • Legal & General Group first reported a position in Zai Lab in Q3 2018 and has held it in 32 quarters since.
  • Legal & General Group's Zai Lab position peaked at $79.2M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.